Harrow, Inc. (HROW)
33.28
-1.13
(-3.28%)
USD |
NASDAQ |
Mar 20, 16:00
33.32
+0.04
(+0.12%)
After-Hours: 20:00
Harrow Research and Development Expense (Quarterly) : 3.273M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 64.86M |
| Esperion Therapeutics, Inc. | 13.93M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Theravance Biopharma, Inc. | 7.362M |
| Rhythm Pharmaceuticals, Inc. | 42.03M |